Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Venous Thrombosis

  Free Subscription


Articles published in Am J Hematol

Retrieve available abstracts of 15 articles:
HTML format



Single Articles


    July 2022
  1. XIAOHUA L, Liu Y, Qu C, Mol B, et al
    The association of iron deficiency anemia, thrombocytosis at delivery and postpartum venous thromboembolism.
    Am J Hematol. 2022 Jul 9. doi: 10.1002/ajh.26657.
    PubMed    


    May 2022
  2. DA COSTA WL JR, Guffey D, Oluyomi A, Bandyo R, et al
    Patterns of venous thromboembolism risk, treatment, and outcomes among patients with cancer from uninsured and vulnerable populations.
    Am J Hematol. 2022 May 31. doi: 10.1002/ajh.26623.
    PubMed     Abstract available


    March 2022
  3. BERG S, Kim SH, Wozniak A, Odetola O, et al
    COVID-19 Thromboembolism Incidence, Risk Factors and Anticoagulation Practices from a Chicago Metropolitan US Population.
    Am J Hematol. 2022 Mar 18. doi: 10.1002/ajh.26541.
    PubMed    


  4. LI A, Martens KL, Nguyen D, Basom R, et al
    External Validation of the HIGH-2-LOW Model: A Predictive Score for Venous Thromboembolism after Allogeneic Transplant.
    Am J Hematol. 2022 Mar 9. doi: 10.1002/ajh.26521.
    PubMed     Abstract available


    November 2021
  5. GERBER GF, DeZern AE, Chaturvedi S, Brodsky RA, et al
    A 15-year, single institution experience of anticoagulation management in paroxysmal nocturnal hemoglobinuria patients on terminal complement inhibition with history of thromboembolism.
    Am J Hematol. 2021 Nov 20. doi: 10.1002/ajh.26414.
    PubMed    


    October 2021
  6. FENYVES BG, Mehta A, Kays KR, Beakes C, et al
    Plasma P-selectin is an early marker of thromboembolism in COVID-19.
    Am J Hematol. 2021 Oct 8. doi: 10.1002/ajh.26372.
    PubMed    


    June 2021
  7. ABOU-ISMAIL MY, Moser KA, Smock KJ, Lim MY, et al
    Vaccine-induced thrombotic thrombocytopenia following Ad26.COV2.S vaccine in a man presenting as acute venous thromboembolism.
    Am J Hematol. 2021 Jun 7. doi: 10.1002/ajh.26265.
    PubMed    


  8. TEFFERI A, Szuber N, Pardanani A, Hanson CA, et al
    Extreme thrombocytosis in low-risk essential thrombocythemia: Retrospective review of vascular events and treatment strategies.
    Am J Hematol. 2021;96:E182-E184.
    PubMed    


    May 2021
  9. KRECAK I, Gardijan B, Brkicic J, Grubisic-Cabo R, et al
    Cryptic brain abscess - do not forget hereditary hemorrhagic teleangiectasia!
    Am J Hematol. 2021;96:640-642.
    PubMed    


    April 2021
  10. ARCHULETA J, van der Graaf M, Kaptein FHJ, Althaus L, et al
    Sudden death due to massive bone marrow sequestration crisis in a patient with sickle cell disease.
    Am J Hematol. 2021;96:E100-E102.
    PubMed    


    March 2021
  11. WARKENTIN TE, Smythe MA, Ali MA, Aslam N, et al
    Serotonin-release assay-positive but platelet factor 4-dependent enzyme-immunoassay negative: HIT or not HIT?
    Am J Hematol. 2021;96:320-329.
    PubMed     Abstract available


    December 2020
  12. HANFF TC, Mohareb AM, Giri J, Cohen JB, et al
    Thrombosis in COVID-19.
    Am J Hematol. 2020;95:1578-1589.
    PubMed     Abstract available


    August 2020
  13. STEFELY JA, Christensen BB, Gogakos T, Cone Sullivan JK, et al
    Marked factor V activity elevation in severe COVID-19 is associated with venous thromboembolism.
    Am J Hematol. 2020 Aug 24. doi: 10.1002/ajh.25979.
    PubMed     Abstract available


    July 2020
  14. GUPTA VK, Strykowski R, Scarpato B, Lawrence R, et al
    The Effect of Anticoagulant Choice on Venous Thromboembolism Recurrence and Bleeding in Sickle Cell Disease.
    Am J Hematol. 2020 Jul 3. doi: 10.1002/ajh.25923.
    PubMed    


    October 2019
  15. CHALAYER E, Teste A, Guyotat D, Elalamy I, et al
    Predicting the risk of venous thromboembolism in newly diagnosed myeloma with immunomodulatory drugs: external validation of the IMPEDE VTE score.
    Am J Hematol. 2019 Oct 15. doi: 10.1002/ajh.25658.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Venous Thrombosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: